A Study of PEGylated Recombinant Human Hyaluronidase (PEGPH20) With Pembrolizumab in Participants With Selected Hyaluronan High Solid Tumors
Clinical trial NCT02563548 · COMPLETED
Trial details
- NCT number
- NCT02563548
- Sponsor
- Halozyme Therapeutics
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-10-22
- Primary completion
- 2019-03-26
- Enrollment
- 56
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.